Condition

Locally Advanced Prostate Carcinoma

ClinicalTrials.gov condition label

Clinical trials5

Recruiting3

Common interventions19

Lead sponsors shown5

Clinical trials

5 shown

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate CancerNCT07073794 · 2025-08-27

Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer SurvivorsNCT06500169 · 2023-09-01

Prospective Prostate Cancer and Patient-reported Outcomes RegistryNCT04694924 · 2020-10-01

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsNCT04550494 · 2021-04-26

ACTIVE_NOT_RECRUITING

Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate CancerNCT04220398 · 2020-01-10

Common interventions

Biospecimen CollectionPROCEDURE2 Questionnaire AdministrationOTHER2 Biopsy ProcedurePROCEDURE1 Cancer Therapeutic ProcedureDRUG1 Computed TomographyPROCEDURE1 DiscussionPROCEDURE1 Exercise InterventionOTHER1 Health Care DeliveryOTHER1 InterviewOTHER1 Magnetic Resonance ImagingPROCEDURE1 Medical Device Usage and EvaluationOTHER1 Neoadjuvant chemotherapy combined with hormone therapyDRUG1 Neoadjuvant hormone therapyDRUG1 Physical ExaminationPROCEDURE1 Physical Performance TestingOTHER1 Radical Prostatectomy (RP)+ extended lymph node dissectionPROCEDURE1 Recreational TherapyOTHER1 standard of careOTHER1 TalazoparibDRUG1

Leading sponsors

Mayo Clinic1 National Cancer Institute (NCI)1 RenJi Hospital1 Universitaire Ziekenhuizen KU Leuven1 University of Southern California1

Trial status mix

RECRUITING3

ACTIVE_NOT_RECRUITING1

UNKNOWN1

Phase mix

NA2

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.